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labelling with iTRAQ reagents and subsequent multidimensional LC-
MS/MS analysis.
Methods: 150 serum samples were obtained from OA patients at
different stages of the disease (grade II, grade IV and control donors)
and were grouped in pools to reduce interindividual variability. The
top twenty most abundant proteins in crude serum ﬂuids were
removed by afﬁnity chromatography using the immunodepletion column
ProteoPrep® 20. Cartilage samples were obtained from OA patients
undergoing joint replacement and normal donors without history of
joint disease. They were extracted with Urea 6M, 2% SDS using a
mixer Mill MM 200 (Retsch). Proteins were quantiﬁed, digested with
trypsin and differentially labelled with isobaric tags using iTRAQ. The
peptide mixture was separated by two dimensional LC coupled to MALDI-
TOF/TOF mass spectrometry. Identiﬁcation and relative quantiﬁcation of
the proteins were performed using ProteinPilot 3.0 software.
Results: Protein proﬁles between the OA patients (early or late) and
healthy controls were compared, leading to the identiﬁcation of 349
proteins. 28 proteins that were altered in OA with statistical signiﬁcance
and more than 1 peptide: 18 of them were increased (OA:Control >1.3,
p < 0.05) and 10 decreased (OA:Control <0.7, p < 0.05). 263 proteins were
identiﬁed in cartilage samples and 59 proteins were quantiﬁed with a
signiﬁcative p-value in OA patients compared to control. The quantiﬁed
proteins of cartilage and serum are involved mainly in biological
functions as extracellular organization, skeletal system development,
cell adhesion, apoptosis, defence and inﬂammatory response. In both
cases it was found that the majority of proteins belonging to the
extracellular matrix region. Identiﬁcation and quantiﬁcation of some
of these proteins both in serum and cartilage from OA patients indicate
their potential biomarker value for the pathology. We detected in both
samples the alteration of proteins such as cartilage oligomeric matrix
protein, lumican, complement factor D or thrombospondin-1, which
were found to be increased in OA, whereas the cytoplasmic actin was
decreased. Finally, a number of other proteins were identiﬁed as altered
either in cartilage (thus increasing our knowledge of OA pathogenesis)
or in serum (which have also potential biomarker value).
Conclusions: In summary, we have identiﬁed for the ﬁrst time a panel
of novel OA protein biomarkers present in serum and cartilage from
human patients by a proteomic approach. The speciﬁcity and selectivity
of these candidates should be veriﬁed in order to develop new molecular
diagnosis or prognosis tests for OA.
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DIFFERENCE GEL ELECTROPHORESIS ANALYSIS OF CARTILAGE
DEGRADATION IN A MOUSE MODEL OF OSTEOARTHRITIS IDENTIFIES
CHANGES IN KEY MOLECULAR PROCESSES
M.D. Gardiner1, L. Gatto2, H. Nagase1. 1Imperial Coll. London, London,
United Kingdom; 2Univ. of Cambridge, Cambridge, United Kingdom
Purpose: The protein proﬁle of cartilage during the initiation and
progression of osteoarthritis (OA) is likely to reﬂect the key early events
in the disease pathogenesis. Studying OA progression using human
cartilage is challenging owing to the difﬁculty in acquiring tissue. The
surgically induced destabilisation of the medial meniscus (DMM) mouse
model provides genetically homogenous cartilage at any disease stage.
Proteomic comparison of diseased and control cartilage identiﬁes protein
changes occurring in early OA.
Methods: The DMM mouse model was used to study the changes in
protein proﬁle of mouse knee articular cartilage during OA. A new
microdissection technique enabled targeted collection of pure mouse
articular cartilage from the medial tibial plateau. Three pooled biological
samples extracted from DMM and control knee joints at 2, 4 and 8 weeks
were compared using difference gel electrophoresis (DIGE). Differentially
expressed spots were identiﬁed by pair wise comparison of normalised
spot intensities from control and OA gels. Protein identiﬁcation from gel
spots was performed by tandemmass spectrometry. Histological sections
were used to assess cartilage degradation. Immunohistochemistry and
real-time RT-PCR were used to further investigate some of the protein
changes.
Results: There were no statistically signiﬁcant differences between DMM
and control cartilage at 2 and 4 weeks. Thirty-nine spots out of 1584
(2.5%) were statistically signiﬁcantly altered in abundance at 8 weeks
following DMM surgery. Thirteen distinct proteins from 26 spots were
increased in DMM cartilage and 5 distinct proteins from 13 spots were
decreased. Small leucine-rich repeat proteins, including biglycan, and
ﬁbromodulin, were signiﬁcantly increased in both protein abundance
and gene expression. Gelsolin, a regulator of the actin cytoskeleton,
protein disulﬁde isomerase A3, ﬁbrinogen beta chain and transitional
endoplasmic reticulum ATPase were also increased. A number of proteins
involved in energy production had an altered abundance; pyruvate
kinase, b-enolase and aconitate hydratase were decreased in abundance,
glycogen phosphorylase was increased.
Conclusions: Application of a new microdissection technique enabled
analysis of the protein proﬁle of pure mouse articular cartilage during
OA progression. This technique can be used to isolate and analyse other
joint tissues. The changes identiﬁed in OA cartilage at eight weeks
were consistent with alterations in energy production, the cytoskeleton
and cell stress. In addition, the greatly increased abundance of SLRPs
adds weight to the importance of these molecules in maintaining
cartilage homeostasis. Their roles extend beyond structural interactions
to encompass important signalling functions.
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Purpose: One of the most widely used compounds in the management of
patients with osteoarthritis (OA) is chondroitin sulfate (CS). The aim of
this work is to study drug modes of action, side-effects, and toxicity
of 3 different CS compounds using two complementary proteomic
approaches.
Methods: Chondrocytes were obtained from 3 OA patients undergoing
joint replacement. The study was approved by the local Ethics
Committee. Proteins expression analysis was carried out using DIGE
(Differential In Gel Electrophoresis) and SILAC (Stable Isotope Labeling
with Amino acids in Cell culture) techniques. In both cases OA
chondrocytes were treated with 200mg/mL of each brand of CS for
48 hours. For DIGE analysis, proteins samples from control and treated
cells were labeled with Cy3 or Cy5 dyes, mixed by pairs and co-
resolved by two-dimensional gel electrophoresis using a pool of all
samples labeled with Cy2 as internal standard. Quantitative image
analysis was performed using Same Spots software. The spots of interest
were analyzed by mass spectrometry (MALDI-MS). Protein identiﬁcation
was carried out by database search (MASCOT). For secretome analysis
by SILAC, cell-conditioned media from isotope-labeled (treated) and
unlabeled (untrated) samples were mixed 1:1, resolved by mono-
dimensional gel electrophoresis, and digested with trypsin. Separation
and analysis of peptides mixtures was performed by nanoﬂow liquid
chromatography coupled off-line to MALDI-MS. In this case protein
identiﬁcation and quantiﬁcation was carried out with Protein Pilot
software.
Results: We examined around 1500 protein spots that were present
in the 6 DIGE gels. We found 46 spots differentially expressed in
our conditions: 27 modulated by CS1, 4 by CS2 and 15 by CS3. We
didn’t observed qualitative changes in the treated cells. We could
identify 28 of the altered spots, corresponding to 18 different proteins.
CS1 strongly modulated mitochondrial superoxide dismutase (SOD2), a
protein previously described by our group as decreased in OA cartilage.
The SILAC experiment allowed us to identify 96 different proteins in
the CS1 secretome, 95 in CS2 and 104 in CS3. CS1 modulated the
expression of 21 proteins: 15 resulted upregulated and 6 downregulated.
CS2 modulated 13 proteins: 5 upregulated and 8 downregulated. Finally
CS3 modulated 9 proteins: 8 upregulated and only 1 downregulated. Each
one of the studied compounds induces a characteristic protein proﬁle
in OA chondrocytes cultures. In the case of CS1 more than 60% of the
altered proteins are speciﬁcally modulated only in this condition. The
same occurs with CS3, while most of the proteins modulated by CS2 are
in common with CS1 and CS3. Despite the highest number of proteins
modulated by CS1, as revealed by DIGE and SILAC experiments, and the
increased expression of SOD2, as above mentioned, some of them are
catabolic or inﬂammatory factors like interstitial collagenase (MMP1),
stromelysin-1 (MMP3) and pentraxin-related protein (PTX3).
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Conclusions: Our results clearly illustrate that not all brands of CS act
similarly: depending on their origin and purity some may be highly
efﬁcacious while others may even induce unwanted effects. Thus, the
use of pharmaceutical-grade CS is strongly recommended. Finally, this
study also indicates that proteomic analysis is a promising approach for
further anti-OA drugs screening.
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STRATEGIES FOR OPTIMISING PROTEOMIC STUDIES OF THE
CARTILAGE SECRETOME: ESTABLISHING THE TIME COURSE FOR
PROTEIN RELEASE AND EVALUATING RESPONSES OF EXPLANT
CULTURES TO IL-1b, TNF-a AND CARPROFEN
A. Williams1, J.R. Smith2, D. Allaway3, P. Harris3, S. Liddell1,
A. Mobasheri1. 1Univ. of Nottingham, Sutton Bonington, United Kingdom;
2Bruker UK Limited, Coventry, United Kingdom; 3WALTHAM Ctr. for Pet
Nutrition, Waltham-on-the-Wolds, United Kingdom
Purpose: This study exploited an explant culture model of articular
cartilage to examine the time course of protein release in the secretome
in response to pro-inﬂammatory cytokines and a non-steroidal anti-
inﬂammatory drug. Aggregating proteoglycans and smaller matrix
proteins such as cartilage oligomeric matrix protein (COMP), decorin
and biglycan are continuously released from this model but their high
abundance interferes with the dynamic range of gel-based separation and
detection techniques and downstream identiﬁcation of lower abundance
molecules. Our aim was to investigate the order and timing of protein
release and determine the optimal time point where the release of these
abundant molecules decreases sufﬁciently, allowing more in-depth high-
throughput analysis in subsequent studies.
Methods: Cartilage was obtained from animals euthanized for purposes
other than research. Explant cultures of equine articular cartilage were
established from metacarpophalangeal joints of 3 horses. Full depth
cartilage shavings were excised and washed with PBS (containing 10%
penicillin/streptomycin). Explant discs were prepared using a 3mm
biopsy punch and pre-incubated in serum-free DMEM supplemented
with 2% penicillin/streptomycin (15 discs per 3ml media) in a CO2
incubator for 24 hours at 37°C. Explants were incubated alone (control
media), or with recombinant IL-1b alone or in combination with TNF-a
(each at 10ng/ml), the non-steroidal anti-inﬂammatory drug carprofen
(Rimadyl, Pﬁzer Animal Health, 100mg/ml) or carprofen with IL-1b and
TNF-a combined (100mg/ml and 10ng/ml respectively). Supernatants
were removed every three days and replaced with fresh experimental
media at various time points (every 24 hours for 3 days, and every 3 days
thereafter, up to 27 days), to monitor the progression of protein release.
Proteins in the secretome were separated by SDS-PAGE and silver stained
before identiﬁcation using nanoLC-ESI-MS/MS analysis.
Fig. 1.
Results: Figure 1 illustrates the time course of protein release from
cartilage explants over a period of 27 days in culture. Table 1 summarizes
information about the proteins identiﬁed from silver-stained 1D-SDS-
PAGE gels. Proteins identiﬁed from SDS-PAGE gels included hyaluronan
and proteoglycan link protein 1, COMP and matrix metalloproteinase
3 (MMP-3), which are in agreement with previous studies from our
laboratory. Treatment with carprofen signiﬁcantly reduced the release
of IL-1b stimulated MMP-3 after 15 days in culture. Furthermore, the
release of abundant molecules decreased in all treatments after 15 days
in culture.
Table 1. Selected proteins identiﬁed from silver-stained 1D-SDS-PAGE
gels.
Protein Name Database Entry Mascot
score
Peptides
matched
Functional Role
Cartilage oligomeric matrix protein,
COMP (Equus caballus)
gi 126352424 463 12 Extracellular matrix
associated protein
involved in collagen
ﬁbril organisation
Matrix metalloproteinase 3, MMP-3
(Equus caballus)
MMP3_HORSE 513 10 Catabolic matrix
metalloproteinase,
involved in
extracellular matrix
degradation
Alpha-enolase (Homo sapiens) gi 2661039 116 3 Intracellular glycolytic
enzyme
Hyaluronan and proteoglycan link
protein 1 (Equus caballus)
HPLN1_HORSE 130 2 Provides the linkage
between hyaluronan
and proteoglycans
Conclusions: The data presented support the view that cartilage explants
continue to release proteins including COMP and MMP-3 in response
to IL-1b treatment for up to 27 days in culture. Future studies using
high-throughput proteomics may allow us to focus on lower abundance
proteins released at critical points during long-term culture experiments
with pro-inﬂammatory cytokines and anti-inﬂammatory drugs. This may
prove to be a useful strategy for identifying new biomarkers and studying
dynamic changes in the secretome of cartilage explants in response to
relevant pathophysiological stimuli.
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THE EFFECT OF AGING IN CARTILAGE ANTIOXIDANT PROTEIN
EXPRESSION AND OSTEOARTHRITIS PROGRESSION IN F344BN RATS
Y. Fu1,2, M. Kinter1, T. Grifﬁn1,2. 1Oklahoma Med. Res. Fndn., Oklahoma
City, OK, USA; 2Univ. of Oklahoma Hlth.Sci. Ctr., Oklahoma City, OK, USA
Purpose: Aging is the primary risk factor for osteoarthritis (OA), a joint
disease involving altered tissue metabolism and increased oxidative
stress. Oxidative stress is believed to contribute to OA progression
by activation of matrix degradation and inhibition of matrix repair.
A decrease in antioxidant protein expression may contribute to the
pro-oxidative state of articular cartilage; however, the cellular anti-
oxidant defense system is redundant making it difﬁcult to assess changes
in antioxidant function without a comprehensive analysis of multiple
antioxidant pathways. We utilized selected reaction monitoring tandem
mass spectrometry, a quantitative proteomics method, to determine the
effect of aging on changes in over 17 antioxidant proteins from rat knee
articular cartilage.
Methods: We studied adult (10 months, N =20) and aged (29 months,
N =19) male F344BN rats, which were purchased from NIH’s Aging
Rodent Colony. Left and right knee joints were sectioned and stained
for histological grading of cartilage OA pathology (N=8 per age). We
developed a proteomic database of target peptide sequences to identify
antioxidant protein expression. Cartilage (N=5 per age) was collected
from the femur and tibia of both knees and frozen at −80C before
analysis. For each sample, 20mg of protein was run into an SDS-PAGE gel
and digested with trypsin in the gel. The peptides were extracted from
the gel and analyzed by a LC-tandem MS system (ThermoScientiﬁc). The
mass spectrometer was operated in the selected reaction monitoring
mode. The parameters for each protein are based on the detection of the
peptides produced by the tryptic digestion.
Results: Aged rats showed signiﬁcantly more OA pathology compared to
adult rats. The average OA cartilage score of aged rats was 2-fold greater
than that for adults. OA scores were greater in the lateral compartment
compared to the medial compartment. Quantitative mass spectrometry
identiﬁed 17 antioxidant proteins that are associated with both the
mitochondria and cytosol (Table 1). The 5 highest expressed proteins in
adult rats were the same as in aged rats, which are Sod1, Gstp1, Akr1b1,
Prdx6 and Prdx2.
Conclusion: We have characterized the F344BN rat as an animal model
of aging associated knee OA. Quantitative proteomics using selected
reaction monitoring provides a novel way for us to proﬁle rat cartilage
antioxidant proteins in a single experiment. 17 antioxidant proteins are
detected in rat cartilage, with Sod, Prdx and Gst being most highly
expressed. These enzymes convert superoxide to hydrogen peroxide
and then hydrogen peroxide to water. These actions make this set of
